![What is multiple myeloma? (Int\](http://img.youtube.com/vi/XqMzT7j2k9U/2.jpg "What is multiple myeloma? (Int\") |
What is multiple myeloma? (Int'l Myeloma Foundation) Posted by: baysidemk
Video duration: 418 seconds 2008 Update: http://tinyurl.com/4 yj898 Dr. Morie Gertz provides an introduction to multiple myeloma, a cancer of the bone marrow, for the newly-diagnosed patient. For more information, contact the International Myeloma Foundation, http://www.myeloma.o rg, theimf@myeloma.org, 800-452-2873 or 818-487-7455 Related: bone, cancer, gertz, haematology, hematology, marrow, myeloma, neoplasm |
 |
ASH 2006 - Dr. Morgan discusses Thalidomide VTEs Posted by: baysidemk
Video duration: 162 seconds Dr. Gareth Morgan discusses the genetic contribution to the etiology of Thalidomide-associat ed Venous Thrombotic Events (VTEs) in multiple myeloma at the 2006 ASH meeting. For more information, contact the International Myeloma Foundation, http://www.myeloma.o rg, theimf@myeloma.org, 800-452-2873 or 818-487-7455 Related: blood, bone, cancer, deep, dvt, genetics, hematology, marrow, multiple, myeloma, thalidomide, throbosis, thrombotic, vein, venous, vte |
 |
What Is Myeloma (Morie Gertz, 2008) Posted by: baysidemk
Video duration: 602 seconds Dr. Morie Gertz of the Mayo Clinic explains the basics. Prepared by the International Myeloma Foundation, 2008. Related: bone, cancer, imf, marrow, mayo, multiple, myeloma, transplant |
 |
Lifeline for the Old - Yad LaKashish - A beautiful story Posted by: baysidemk
Video duration: 593 seconds Lifeline for the Old is a wonderful place in Jerusalem where over 270 elderly people are employed in ten workshops making beautiful Judaica and gifts. Lifeline also provides a broad array of social and health care services to the elderly. Learn more about this beautiful story by viewing this video. Related: caring, charity, elderly, israel, social |
 |
Bank on a Cure: Groundbreaking Multiple Myeloma Research Posted by: baysidemk
Video duration: 102 seconds During the last decade scientists mapped the human genome providing a bridge to understanding human DNA. During the first decade of this century the International Myeloma Foundation (http://www.myeloma. org)is crossing that bridge by pioneering the first global myeloma-specific DNA bank in history: BANK ON A CUREŽ. Related: biology, cancer, genetics, genome, hematology, molecular, multiple, myeloma, snps |
 |
ASCO 2007 - Dr. Rajkumar presents Revlimid/Dex Results Posted by: baysidemk
Video duration: 245 seconds Dr. Vincent Rajkimar provides an update on a trial of Revlimid with dexamethasone in multiple myeloma at the 2007 ASCO meeting. This trial concluded that lower doses of dex produced superior results. For more information, contact the International Myeloma Foundation, http://www.myeloma.o rg, theimf@myeloma.org, 800-452-2873 or 818-487-7455 Related: bone, cancer, dexamethasone, dose, hematology, lenalidomide, low, marrow, multiple, myeloma, revlimid, steroid |
 |
ASH 2006 - Dr. Dispenzieri discusses Velcade Results Posted by: baysidemk
Video duration: 200 seconds Dr. Angela Dispenzieri discusses results of trial using Velcade in patients with newly-diagnosed high-risk multiple myeloma at the 2006 ASH meeting. For more information, contact the International Myeloma Foundation, http://www.myeloma.o rg, theimf@myeloma.org, 800-452-2873 or 818-487-7455 Related: bone, bortezomib, cancer, hematology, high, marrow, multiple, myeloma, risk, velcade |
 |
ASH 2007 Overview by Dr. Sundar Jagannath Posted by: baysidemk
Video duration: 311 seconds "At ASH, we had numberous presentations showing that combinations using novel agents are allowing us to achieve very high complete remission rates and is changing the treatment options for newly-diagnosed patients." Dr. Sundar Jagannath This video provided by the International Myeloma Foundation (http://www.myeloma. org) Related: ash, cancer, hematology, multiple, myeloma |
 |
ASH 2006 - Dr. Harousseau discusses Velcade Results Posted by: baysidemk
Video duration: 301 seconds Dr. Jean-Luc Harousseau discusses results of a trial comparing VAD with Velcade plus dexamethasone as indcution therapy in newly-diagnosed high-risk multiple myeloma at the 2006 ASH meeting. For more information, contact the International Myeloma Foundation, http://www.myeloma.o rg, theimf@myeloma.org, 800-452-2873 or 818-487-7455 Related: bone, bortezomib, cancer, hematology, high, marrow, multiple, myeloma, risk, transplant, velcade |
 |
ASCO 2007 - Dr. Keith Stewart discusses carfilzomib trial Posted by: baysidemk
Video duration: 131 seconds Dr. Keith Stewart provides an update on trials of a new proteosome inhibitor (carfilzomib) in multiple myeloma from the 2007 ASCO meeting. For more information, contact the International Myeloma Foundation, http://www.myeloma.o rg, theimf@myeloma.org, 800-452-2873 or 818-487-7455 Related: asco, bone, cancer, carfilzomib, hematology, marrow, multiple, myeloma |
 |
ASH 2006 - Dr. Niesvizky disscusses Revlmid Results Posted by: baysidemk
Video duration: 266 seconds Dr. Ruben Niesvizky discusses potential role of renal insuffieciciency in patients treated with the Biaxin Revlimid and Dexamethasone (BIRD) protocol multiple myeloma at the 2006 ASH meeting. For more information, contact the International Myeloma Foundation, http://www.myeloma.o rg, theimf@myeloma.org, 800-452-2873 or 818-487-7455 Related: biaxin, blood, bone, cancer, dexamethasone, hematology, lenalidomide, marrow, multiple, myeloma, renal, revlimid, steroid |
 |
ASH 2006 - Dr. Lacy discussess revlimid/dex results Posted by: baysidemk
Video duration: 231 seconds Dr. Martha Lacy discusses results of a Phase II trial of Revlimid/Dexamethaso ne in relapsed refractory multiple myeloma at the 2006 ASH meeting. For more information, contact the International Myeloma Foundation, http://www.myeloma.o rg, theimf@myeloma.org, 800-452-2873 or 818-487-7455 Related: bone, cancer, dexamethasone, dose, hematology, lenalidomide, low, marrow, multiple, myeloma, revlimid, steroid |
 |
ASH 2006 Dr. Palumbo discusses Velcade, Thalidomide Results Posted by: baysidemk
Video duration: 136 seconds Dr. Antonio Palumbo discusses results of a trial of Velcade, Thalidomide with Melphalan plus Prednisone in relapsed multiple myeloma at the 2006 ASH meeting. For more information, contact the International Myeloma Foundation, http://www.myeloma.o rg, theimf@myeloma.org, 800-452-2873 or 818-487-7455 Related: bone, bortezomib, cancer, hematology, marrow, melphalan, multiple, myeloma, prednisone, relapsed, thalidomide, velcade |
 |
ASCO 2007 - Dr. Harousseau presents Velcade/doxirubicin Posted by: baysidemk
Video duration: 217 seconds Dr. Jean-Luc Harousseau provides an update on trials Velcade with pegolated doxirubucin in multiple myeloma at the 2007 ASCO meeting. For more information, contact the International Myeloma Foundation, http://www.myeloma.o rg, theimf@myeloma.org, 800-452-2873 or 818-487-7455 Related: asco, bone, cancer, doxirubicin, harousseau, hematology, marrow, multiple, myeloma, pegolated |
 |
2006 ASH Meeting Multiple Myeloma Overview Posted by: baysidemk
Video duration: 100 seconds Dr. Morie Gertz discusses research presented at the 2006 meeting of the American Society of Hematology about multiple myeloma, a cancer of the bone marrow. For more information, contact the International Myeloma Foundation, http://www.myeloma.o rg, theimf@myeloma.org, 800-452-2873 or 818-487-7455 Related: bone, cancer, cell, hematology, marrow, myeloma, neoplasm, stem |
 |
Elijah Alexander attends ASH 2007 Posted by: baysidemk
Video duration: 72 seconds Former NFL lineman and Myeloma Survivor Elijah Alexander shares his reactions on attending the American Society Of Hematology Annual Meeting for the first time. This video provided by the International Myeloma Foundation (http://www.myeloma. org) Related: ash, cancer, hematology, multiple, myeloma |
 |
ASH 2006 - Dr. Dispenzieri discusses Revlimid Results Posted by: baysidemk
Video duration: 121 seconds Dr. Angela Dispenzieri discusses results of a Phase II trial of Revlimid/Dexamethaso ne in primary systemic amyloidosis at the 2006 ASH meeting. For more information, contact the International Myeloma Foundation, http://www.myeloma.o rg, theimf@myeloma.org, 800-452-2873 or 818-487-7455 Related: amyloidosis, cancer, lenalidomide, myeloma, primary, revlimid, systemic |
 |
ASH 2006 - Dr. Palumbo discusses Revlimid results Posted by: baysidemk
Video duration: 92 seconds Dr. Antonio Palumbo discusses results of a Revlimid with Melphalan plus prednisone in newly-diagnosed multiple myeloma at the 2006 ASH meeting. For more information, contact the International Myeloma Foundation, http://www.myeloma.o rg, theimf@myeloma.org, 800-452-2873 or 818-487-7455 Related: bone, cancer, dexamethasone, lenalidomide, marrow, melphalan, multiple, myeloma, prednisone, revlimid, steroid |
 |
Stem Cell Transplant Update by Dr. Bensinger from ASCO 2007 Posted by: baysidemk
Video duration: 595 seconds Dr. Bill Bensinger provides an update on stem cell tranplantation in multiple myeloma from the 2007 ASCO meeting. For more information, contact the International Myeloma Foundation, http://www.myeloma.o rg, theimf@myeloma.org, 800-452-2873 or 818-487-7455 Related: bone, cancer, cell, hematology, marrow, myeloma, stem, transplant |
 |
ASH 2006 - Dr. Chanan Khan reports Revlimid Results Posted by: baysidemk
Video duration: 102 seconds Dr. Chanan Khan discusses results of a Phase II trial of Revlimid/Dexamethaso ne in relapsed refractory multiple myeloma at the 2006 ASH meeting. For more information, contact the International Myeloma Foundation, http://www.myeloma.o rg, theimf@myeloma.org, 800-452-2873 or 818-487-7455 Related: bone, cancer, dexamethasone, dose, hematology, lenalidomide, low, marrow, multiple, myeloma, revlimid, steroid |
 |
ASH 2006 - Dr. Jagannath discusses Velcade Results Posted by: baysidemk
Video duration: 245 seconds Dr. Sundar Jagannath discusses results of a Velcade with dexamethasone in newly-diagnosed multiple myeloma at the 2006 ASH meeting. For more information, contact the International Myeloma Foundation, http://www.myeloma.o rg, theimf@myeloma.org, 800-452-2873 or 818-487-7455 Related: bone, bortezomib, cancer, hematology, marrow, multiple, myeloma, velcade |
